Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent hemolytic uremic syndrome.

Richard L Siegler, Andrew T Pavia, Joseph R Sherbotie

    Clinical Pediatrics
    |December 5, 2002
    PubMed
    Summary

    This study explores rare cases of hemolytic uremic syndrome (HUS) in children where the condition recurred without a diarrheal prodrome following an initial episode linked to Shiga toxin-producing E. coli. Two unrelated female patients experienced multiple non-diarrheal HUS episodes after an initial diarrheal event. The authors propose that these recurrences are not due to reinfection with the same bacteria but may involve other factors such as genetic predisposition. The study introduces a classification system for HUS that includes recurrence risk, highlighting that familial HUS is most likely to recur. The findings suggest that clinicians should consider recurrence risk when managing HUS patients, especially those with a history of familial or drug-induced HUS.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Derivation and validation of clinical prediction models for viral etiologies of acute diarrhea in North American children presenting for emergency care.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Health, economic, and equity impact of a COVID-19 mobile vaccine clinic program in US: a cost-effectiveness analysis.

    Lancet regional health. Americas·2026
    Same author

    Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis.

    NEJM evidence·2026
    Same author

    Association between Weather Variables and Viral Gastroenteritis in the United States.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Effectiveness of mobile vaccine clinics on COVID-19 vaccination uptake in the USA: an observational study.

    BMJ public health·2026
    Same author

    Shiga Toxin-Producing Escherichia coli Outbreak in Canadian Daycare Centers.

    JAMA network open·2026

    Area of Science:

    • Pediatric nephrology
    • Infectious disease epidemiology
    • Clinical hematology

    Background:

    Hemolytic uremic syndrome (HUS) is a rare condition affecting children and is often preceded by diarrhea. Most cases are associated with Shiga toxin-producing E. coli (STEC) infections. A small proportion of HUS cases occur without a diarrheal prodrome (D- HUS). Prior studies have focused on the acute presentation of HUS, but less is known about its recurrence patterns. Non-diarrheal recurrences following an initial D+ episode are not widely documented in clinical literature. This gap motivated researchers to examine the phenomenon of D- recurrences in detail. No prior work had resolved the frequency or mechanisms behind such recurrences. Understanding recurrence patterns is crucial for managing long-term patient outcomes. The lack of a standardized classification system for HUS recurrence has limited progress in this area. This paper contributes by identifying and analyzing rare recurrence cases.

    Purpose Of The Study:

    The study aimed to investigate the occurrence of non-diarrheal (D-) recurrences following an initial diarrheal (D+) episode of HUS. The researchers focused on two unrelated female patients who experienced multiple D- episodes after an initial D+ HUS event. The goal was to highlight the existence of this rare recurrence pattern. They also sought to expand the understanding of HUS recurrence beyond the well-known STEC-related cases. The motivation was to address the lack of awareness and documentation regarding D- recurrences. By presenting these cases, the authors intended to stimulate further research into recurrence mechanisms. The study also aimed to introduce a new classification system for HUS that includes recurrence risk. This approach could improve diagnostic accuracy and patient management strategies.

    Keywords:
    Hemolytic uremic syndromeNon-diarrheal HUSHUS recurrencePediatric nephrology

    Frequently Asked Questions

    The authors suggest that non-diarrheal recurrences may involve genetic or immune-related factors rather than reinfection with Shiga toxin-producing E. coli.

    The system includes familial, drug-induced, cancer-related, and pregnancy-associated HUS, each with different recurrence risks.

    The authors propose that these recurrences are not due to STEC reinfection, as the patients did not experience a diarrheal prodrome.

    Familial HUS is associated with the highest recurrence risk according to the classification system presented in the study.

    Related Experiment Videos

    Main Methods:

    The researchers conducted a clinical case review of two unrelated female patients with a history of D+ HUS followed by multiple D- recurrences. They analyzed medical records to identify the timeline and characteristics of each HUS episode. The study included a literature review to contextualize the rarity of D- recurrences. The authors developed a classification system for HUS that incorporates recurrence risk factors. This system categorizes cases based on etiology and recurrence likelihood. The classification was informed by clinical observations and existing diagnostic criteria. The researchers also examined the role of familial, drug-induced, and pregnancy-related factors in recurrence. The study combined descriptive analysis with a novel framework for classifying HUS cases.

    Main Results:

    The first patient experienced three D- HUS recurrences over several years following an initial D+ episode. The second patient had four D- episodes after an initial D+ diagnosis. Both cases were unrelated and occurred in non-familial settings. The recurrence pattern was distinct from typical STEC-related HUS. The classification system revealed that familial HUS had the highest recurrence risk. Drug-induced and pregnancy-related cases also showed recurrence potential. The study found that D- recurrences were not linked to STEC reinfection. The authors propose that other mechanisms, such as genetic predisposition, may be involved.

    Conclusions:

    The authors conclude that non-diarrheal recurrences of HUS following an initial diarrheal episode are rare but possible. The two cases presented in the study demonstrate that D- recurrences can occur independently of STEC reinfection. The classification system introduced in the paper provides a framework for assessing recurrence risk. This system highlights that familial HUS is most likely to recur. Drug-induced and pregnancy-related HUS also show recurrence potential. The study emphasizes the need for further research into the mechanisms of D- recurrences. The findings suggest that recurrence patterns may vary based on the underlying cause of HUS. The authors propose that clinicians consider recurrence risk when managing HUS patients.

    The study tracks the number of recurrences, the time between episodes, and the presence or absence of a diarrheal prodrome.

    The authors suggest that clinicians should consider recurrence risk when managing HUS patients, particularly those with familial or drug-induced cases.